Please Wait...

Jeremiah Rehm

Main profile

Jeremiah Rehm
Jeremiah Rehm
Clinical Solutions Specialist

Jeremiah has been an innovator in Life Sciences for more than 13 years -- the last 8 of those designing and maintaining Clinical Trial Management Systems. Prior to joining Bioclinica, he was a technology consultant and led the product management team for eClinical products acquired by Bioclinica. One of Jeremiah's specialties is in the use of Microsoft applications to consolidate and analyze operational study information, including translation of this data into meaningful performance metrics.

Blogs

Regulatory authorities require clinical trial progress to be monitored. The site visit report, known as the Monitor Visit Report (MVR), is where sponsors provide evidence that all regulated activities have been completed along with documentation of the outcome. These reports are open to regulatory inspection at any time during a study, as well as after, and even post product approval.

CTMS and MVR, Across the Great Divide
As anyone in pharma knows, our industry is undergoing major change; clinical trials are rapidly evolving and eClinical technologies are becoming more sophisticated by the day. Meanwhile site monitoring continues to be one of the most critical, costly, and labor-intensive activities in a clinical trial. Looking for a better way to address this, many organizations have made the switch from conventional CTMS to the "Microsoft Office-Smart" model.

CTMS & eTMF seamless integration at ShareFEST 2013

We've recently heard quite a bit of industry conversation regarding the touch-points between clinical trial management systems (CTMS) and electronic trial master files (eTMF).  In addition to this blog post, we will be discussing this evolving topic in greater depth at the upcoming ShareFEST 2013 conference i

There have recently been a lot of industry conversations regarding the touch-points between clinical trial management systems (CTMS) and Electronic Master Trial Files (eTMF). While there are many questions concerning the integration of CTMS and eTMF, they can mostly be boiled down to the following three:

There has been quite a lot of discussion within the clinical trial management industry regarding new improved CTMS and study setup products. These new CTMS solutions all seem to focus on updating the traditional model with a slick, user-friendly interface as well as overall improved functionality (which is great).

Webinars

December 31, 2019 - 12:00pm (EST)

In this webinar hosted by Chad Ebner, who heads up Bioclinica's App xChange, clinical trial experts Dirk Beth and Jeremiah Rehm will explore the possibilities of single source data across CTMS/eTMF systems. This approach can bring increased efficiencies in a number of important areas, such as elimination of redundant work processes and reconciliation of CTMS/eTMF data.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (5 hours ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (Yesterday)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (Yesterday)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will give a… https://t.co/8ymd2Q9KcJ
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will giv… https://t.co/MpxTDV1T1L
bioclinica (Yesterday)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices